Open Access

[Corrigendum] Polydatin inhibits hepatocellular carcinoma via the AKT/STAT3‑FOXO1 signaling pathway

  • Authors:
    • Jian Jiang
    • Yaodong Chen
    • Tianxiu Dong
    • Minlu Yue
    • Yu Zhang
    • Tingting An
    • Jiuwei Zhang
    • Pengfei Liu
    • Xiuhua Yang
  • View Affiliations

  • Published online on: September 12, 2019     https://doi.org/10.3892/ol.2019.10856
  • Pages: 5654-5654
  • Copyright : © Jiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

November-2019
Volume 18 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jiang J, Chen Y, Dong T, Yue M, Zhang Y, An T, Zhang J, Liu P and Yang X: [Corrigendum] Polydatin inhibits hepatocellular carcinoma via the AKT/STAT3‑FOXO1 signaling pathway. Oncol Lett 18: 5654-5654, 2019
APA
Jiang, J., Chen, Y., Dong, T., Yue, M., Zhang, Y., An, T. ... Yang, X. (2019). [Corrigendum] Polydatin inhibits hepatocellular carcinoma via the AKT/STAT3‑FOXO1 signaling pathway. Oncology Letters, 18, 5654-5654. https://doi.org/10.3892/ol.2019.10856
MLA
Jiang, J., Chen, Y., Dong, T., Yue, M., Zhang, Y., An, T., Zhang, J., Liu, P., Yang, X."[Corrigendum] Polydatin inhibits hepatocellular carcinoma via the AKT/STAT3‑FOXO1 signaling pathway". Oncology Letters 18.5 (2019): 5654-5654.
Chicago
Jiang, J., Chen, Y., Dong, T., Yue, M., Zhang, Y., An, T., Zhang, J., Liu, P., Yang, X."[Corrigendum] Polydatin inhibits hepatocellular carcinoma via the AKT/STAT3‑FOXO1 signaling pathway". Oncology Letters 18, no. 5 (2019): 5654-5654. https://doi.org/10.3892/ol.2019.10856